More Articles

Overview of research on biosimilarity/comparability and interchangeability of biosimilars 2012 Biosimilars/Research | Posted 12/10/2012

Period: January to August 2012 After the patent on a biological medicine expires ‘similar’ versions of the originator biological can be produced. These biosimilars or ‘similar biological medic...

Teva halts phase III biosimilar rituximab trial Biosimilars/News | Posted 12/10/2012

Israeli generics giant Teva Pharmaceutical Industries (Teva) has suspended its phase III trial of its biosimilar version (TL011) of Roche’s Rituxan/MabThera (rituximab).

FDA gives generics greater importance Generics/General | Posted 12/10/2012

The Office of Generic Drugs has been promoted to the highest position within FDA because of the great amount of work and income/expenditure now associated with generics.

India plans further cuts to drug prices Policies & Legislation | Posted 12/10/2012

The Indian government has announced plans to further extend price cuts on both generic and brand-name drugs in order to try to improve access to affordable medicines in the country.

Sanofi to acquire Colombian generics maker Pharma News | Posted 12/10/2012

Healthcare major Sanofi announced on 2 October 2012 that it has signed an agreement to acquire Colombian generics manufacturer Laboratorios Genfar (Genfar), making Sanofi a market leader in Colombi...

Boehringer Ingelheim completes biosimilar adalimumab trial Biosimilars/Research | Posted 12/10/2012

Biopharmaceutical specialist Boehringer Ingelheim Pharmaceuticals (Boehringer Ingelheim) has completed its phase I trial for a biosimilar version of adalimumab.

GPhA drug shortages plan gets FTC approval Pharma News | Posted 12/10/2012

On 8 August 2012 the US Federal Trade Commission (FTC) issued a positive advisory opinion to the Generic Pharmaceutical Association (GPhA) approving its Accelerated Recovery Initiative (ARI), which...

Mylan debuts first generic Diovan HCT and Antivert in USA Generics/News | Posted 12/10/2012

Mylan is first off the mark once again with its latest generics launch. Mylan announced on 21 September 2012 that its subsidiary Mylan Pharmaceuticals has received final approval from FDA for its A...